Outset Medical (NASDAQ:OM) reported quarterly losses of $(3.24) per share which missed the analyst consensus estimate of $(0.94) by 244.68 percent. This is a 62.11 percent increase over losses of $(8.55) per share from the same period last year. The company reported quarterly sales of $29.75 million which beat the analyst consensus estimate of $27.81 million by 6.98 percent. This is a 5.62 percent increase over sales of $28.17 million the same period last year.